Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
|
+$465M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$268M |
| 3 |
Verizon
VZ
|
+$239M |
| 4 |
Microsoft
MSFT
|
+$212M |
| 5 |
Apple
AAPL
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$421M |
| 2 |
Becton Dickinson
BDX
|
+$213M |
| 3 |
Home Depot
HD
|
+$191M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$132M |
| 5 |
Broadcom
AVGO
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.96% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.98% |
| 4 | Consumer Discretionary | 10.85% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRG
2126
Seritage Growth Properties
SRG
$137M
| $7.91M | ﹤0.01% |
595,693
+22,999
| +4% | +$337K |
|
2127
Credicorp
BAP
$31.6B
| $7.9M | ﹤0.01% |
64,728
+13,086
| +25% | +$1.6M |
|
2128
Senseonics Holdings Inc
SENS
$274M
| $7.84M | ﹤0.01% |
146,868
+2,254
| +2% | +$146K |
|
2129
Zillow
ZG
$8.12B
| $7.84M | ﹤0.01% |
126,013
+8,497
| +7% | +$610K |
|
2130
Myers Industries
MYE
$1.34B
| $7.83M | ﹤0.01% |
391,561
+12,008
| +3% | +$243K |
|
2131
Axsome Therapeutics
AXSM
$10.7B
| $7.83M | ﹤0.01% |
207,230
+3,178
| +2% | +$117K |
|
2132
MGP Ingredients
MGPI
$373M
| $7.83M | ﹤0.01% |
92,123
+946
| +1% | +$71.3K |
|
|
RVNC
2133
DELISTED
Revance Therapeutics, Inc.
RVNC
| $7.78M | ﹤0.01% |
476,824
+5,557
| +1% | +$92.6K |
|
2134
Agilysys
AGYS
$3.08B
| $7.77M | ﹤0.01% |
174,825
+4,623
| +3% | +$220K |
|
2135
MannKind Corp
MNKD
$1.18B
| $7.74M | ﹤0.01% |
1,770,776
+34,016
| +2% | +$157K |
|
2136
Nuvation Bio
NUVB
$2.18B
| $7.72M | ﹤0.01% |
907,673
+212,255
| +31% | +$1.95M |
|
|
CONN
2137
DELISTED
Conn's Inc.
CONN
| $7.72M | ﹤0.01% |
328,035
-18,112
| -5% | -$408K |
|
2138
Gates Industrial Corporation Ltd.
GTES
$7.28B
| $7.65M | ﹤0.01% |
480,924
+12,285
| +3% | +$201K |
|
2139
Alpha and Omega Semiconductor
AOSL
$956M
| $7.65M | ﹤0.01% |
126,327
+2,529
| +2% | +$110K |
|
2140
Nurix Therapeutics
NRIX
$2.4B
| $7.63M | ﹤0.01% |
263,640
+3,880
| +1% | +$118K |
|
2141
Compass Diversified
CODI
$785M
| $7.61M | ﹤0.01% |
248,916
-5,104
| -2% | -$155K |
|
2142
Gogo Inc
GOGO
$609M
| $7.61M | ﹤0.01% |
562,581
+112,504
| +25% | +$1.67M |
|
2143
Coherus Oncology
CHRS
$221M
| $7.58M | ﹤0.01% |
475,237
+7,879
| +2% | +$138K |
|
2144
Financial Institutions
FISI
$836M
| $7.56M | ﹤0.01% |
237,780
+3,511
| +1% | +$112K |
|
2145
Banc of California
BANC
$3.05B
| $7.54M | ﹤0.01% |
384,070
+76,273
| +25% | +$1.54M |
|
2146
Nicolet Bankshares
NIC
$3.67B
| $7.52M | ﹤0.01% |
87,735
+12,594
| +17% | +$960K |
|
2147
Seaboard Corp
SEB
$4.26B
| $7.47M | ﹤0.01% |
1,899
+77
| +4% | +$307K |
|
|
MCHB
2148
Mechanics Bancorp
MCHB
$3.76B
| $7.45M | ﹤0.01% |
143,295
-1,911
| -1% | -$92.1K |
|
2149
nLIGHT
LASR
$4.04B
| $7.45M | ﹤0.01% |
311,058
+9,913
| +3% | +$261K |
|
2150
Liberty Media Series A
FWONA
$22.4B
| $7.44M | ﹤0.01% |
130,995
-2,975
| -2% | -$154K |
|
Similar funds
Charles Schwab's Q4 2021 Portfolio in Review
As of Q4 2021, Charles Schwab held 3,647 positions worth $339B, up 11% from $306B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Charles Schwab's Q4 2021 filing shows 148 new, 2,572 increased, 501 reduced and 58 closed positions. Its largest new stake was Kyndryl: 2,951,149 shares worth $53.4M. The largest sale was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, an estimated $421M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2021 buy was Kyndryl: 2,951,149 shares worth $53.4M.
- Charles Schwab added most to State Street SPDR Portfolio Short Term Treasury ETF in Q4 2021, an estimated $465M increase.
- Charles Schwab's biggest Q4 2021 reduction was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, cutting an estimated $421M.
- Charles Schwab fully exited Kansas City Southern in Q4 2021, selling an estimated $113M.
- Charles Schwab's ten largest holdings make up 18% of its $339B portfolio in Q4 2021.
- Charles Schwab opened 148 new positions and closed 58 in Q4 2021.
- Charles Schwab's portfolio value rose 11% quarter-over-quarter to $339B.
Based on Charles Schwab's 13F filing for Q4 2021, filed 11 Feb 2022.